GlassScriptPhysician profile
Benjamin Britton Zorach
NPI 1679969158
$7,595.08
in general payments reported to CMS, 2019-2025
11 companies · $4,469 in 2025
The $4,469 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $442 · 2022: $1,848 · 2023: $711 · 2024: $124 · 2025: $4,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,580 · Food and Beverage: $1,744 · Travel and Lodging: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,580.00 |
| Food and Beverage | $1,744.29 |
| Travel and Lodging | $980.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,241.06 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,930.88 | 2021-2025 | Corevalve Evolut R, Hawkone |
| Abbott Laboratories | $1,578.56 | 2023-2025 | Triclip, Hi-Torque Balance, Mitraclip |
| Boston Scientific Corporation | $369.82 | 2021-2024 | Watchman Flx, Avvigo Guidance System, Rotapro |
| Cardiovascular Systems INC. | $300.85 | 2021-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $47.09 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $43.14 | 2022 | |
| Pfizer INC. | $36.92 | 2022 | |
| Teleflex LLC | $27.82 | 2021-2022 | |
| Terumo Medical Corporation | $18.94 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Zorach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.